GB9216102D0 - Pharmaceutical substances - Google Patents

Pharmaceutical substances

Info

Publication number
GB9216102D0
GB9216102D0 GB929216102A GB9216102A GB9216102D0 GB 9216102 D0 GB9216102 D0 GB 9216102D0 GB 929216102 A GB929216102 A GB 929216102A GB 9216102 A GB9216102 A GB 9216102A GB 9216102 D0 GB9216102 D0 GB 9216102D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical substances
pharmaceutical
substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929216102A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB929216102A priority Critical patent/GB9216102D0/en
Publication of GB9216102D0 publication Critical patent/GB9216102D0/en
Priority to AU47172/93A priority patent/AU4717293A/en
Priority to PCT/GB1993/001589 priority patent/WO1994003168A1/en
Priority to CN93116820A priority patent/CN1095721A/en
Priority to ZA935430A priority patent/ZA935430B/en
Priority to MX9304548A priority patent/MX9304548A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB929216102A 1992-07-29 1992-07-29 Pharmaceutical substances Pending GB9216102D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB929216102A GB9216102D0 (en) 1992-07-29 1992-07-29 Pharmaceutical substances
AU47172/93A AU4717293A (en) 1992-07-29 1993-07-27 5 s penem derivatives, their preparation and use
PCT/GB1993/001589 WO1994003168A1 (en) 1992-07-29 1993-07-27 5 s penem derivatives, their preparation and use
CN93116820A CN1095721A (en) 1992-07-29 1993-07-27 New compounds
ZA935430A ZA935430B (en) 1992-07-29 1993-07-28 5 S penem derivatives their preparation and use
MX9304548A MX9304548A (en) 1992-07-29 1993-07-28 NEW PENEM COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS INCLUDING THEM.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929216102A GB9216102D0 (en) 1992-07-29 1992-07-29 Pharmaceutical substances

Publications (1)

Publication Number Publication Date
GB9216102D0 true GB9216102D0 (en) 1992-09-09

Family

ID=10719485

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929216102A Pending GB9216102D0 (en) 1992-07-29 1992-07-29 Pharmaceutical substances

Country Status (6)

Country Link
CN (1) CN1095721A (en)
AU (1) AU4717293A (en)
GB (1) GB9216102D0 (en)
MX (1) MX9304548A (en)
WO (1) WO1994003168A1 (en)
ZA (1) ZA935430B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2774199A (en) * 1998-02-19 1999-09-06 Washington University Beta-lactam-like chaperone inhibitors
EP2474318A1 (en) 2006-06-07 2012-07-11 Human Genome Sciences, Inc. Albumin fusion proteins

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0042026B1 (en) * 1978-02-02 1986-01-08 Ciba-Geigy Ag 3,4-disubstituted azetidin-2-on compounds and process for their preparation
GB2036015A (en) * 1978-11-22 1980-06-25 Beecham Group Ltd Process for preparing penem derivatives
GB2037277B (en) * 1978-12-22 1983-05-05 Beecham Group Ltd -lactam antibacterial agents their use in pharmaceutical compositions processes for their preparation and intermediates for use in such processes
IL59081A0 (en) * 1979-01-10 1980-05-30 Schering Corp 2-penem compounds and a method for preparing them
US4282236A (en) * 1979-11-07 1981-08-04 Beecham Group Limited β-Lactam antibacterial agents, their use in pharmaceutical compositions, and intermediates
EP0125208A1 (en) * 1983-05-06 1984-11-14 Ciba-Geigy Ag Amino-lower-alkyl-penem derivatives, process for their preparation, pharmaceutical compositions containing them and their use
JPH0696580B2 (en) * 1985-09-17 1994-11-30 三共株式会社 Penem-3-carboxylic acid derivative
GB8713515D0 (en) * 1987-06-10 1987-07-15 Erba Farmitalia Methoxymethyl compounds
EP0399228A1 (en) * 1989-04-29 1990-11-28 Hoechst Aktiengesellschaft Process for the preparation of penem compounds
AU646577B2 (en) * 1991-07-09 1994-02-24 Banyu Pharmaceutical Co., Ltd. 2-(2-substituted pyrrolidinylthio)carbapenem derivatives

Also Published As

Publication number Publication date
CN1095721A (en) 1994-11-30
WO1994003168A1 (en) 1994-02-17
MX9304548A (en) 1994-05-31
AU4717293A (en) 1994-03-03
ZA935430B (en) 1994-04-12

Similar Documents

Publication Publication Date Title
PH30215A (en) Pharmaceutical compounds
GB9319500D0 (en) Pharmaceutical composition
GB2272375B (en) Pharmaceutical composition
HU9303261D0 (en) Pharmaceutical compounds
HU9300804D0 (en) Pharmaceutical preparatives
GB9221707D0 (en) Pharmaceutical composition
CZ87895A3 (en) Pharmaceutical preparation
ZA935078B (en) Pharmaceutical composition
GB9216102D0 (en) Pharmaceutical substances
GB9226724D0 (en) Pharmaceutical compounds
ZA938546B (en) Pharmaceutical compounds
ZA924061B (en) Pharmaceutical composition
ZA935931B (en) Pharmaceutical composition
GB9211379D0 (en) Pharmaceutical compounds
GB9224013D0 (en) Ws75624 substances
PL298159A1 (en) Pharmaceutical preparation
GR1002176B (en) Pharmaceutical substances.
GB9213058D0 (en) Pharmaceutical compounds
GB9226895D0 (en) Pharmaceutical compounds
GB9209028D0 (en) Pharmaceutical compounds
GB9222650D0 (en) Pharmaceutical compounds
GB9204302D0 (en) Pharmaceutical compounds
GB9218091D0 (en) Pharmaceutical compounds
GB9218092D0 (en) Pharmaceutical compounds
GB9218090D0 (en) Pharmaceutical compounds